Risk Factors for Serious Adverse Effects of Thiopurines in Patients with Crohn’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|8|3|181-185

ISSN： 1574-8863

Source： Current Drug Safety, Vol.8, Iss.3, 2013-07, pp. : 181-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 7, 2015-10 ,pp. : 867-879

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 3, 2018-03 ,pp. : 608-614

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence and Risk Factors for Urolithiasis in Patients with Crohn's Disease

By  

Urologia Internationalis, Vol. 95, Iss. 3, 2015-0 ,pp. : 314-319

Karger

Access to resources Recommend Favorite

Ileum resection is the most predictive factor for osteoporosis in patients with Crohn’s disease

By Hogezand R.   Bänffer D.   Zwinderman A.   McCloskey E.   Griffioen G.   Hamdy N.  

Osteoporosis International, Vol. 17, Iss. 4, 2006-04 ,pp. : 535-542

Springer Publishing Company

Access to resources Recommend Favorite

Derivation of a risk scale and quantification of risk factors for serious adverse events in adult emergency department syncope patients

By  

Canadian Journal of Emergency Medicine, Vol. 16, Iss. 2, 2014-03 ,pp. : 120-130

Cambridge University Press

Access to resources Recommend Favorite